W.H. Ireland Group

PDMR Shareholdings

RNS Number : 4392Z
W.H. Ireland Group PLC
24 January 2022
 

 

 

WH Ireland Group Plc

 

("WH Ireland" or the "Company")

 

PDMR shareholdings

Philip Wale, Chief Executive has informed the Company that he has purchased 35,000 ordinary shares in the Company as set out below. Following these purchases, Phillip Wale owns 206,295 ordinary shares, representing 0.33 per cent. of the issued share capital in the Company.  

The notifications set out below are provided in accordance with the requirements of the EU Market Abuse Regulation.

1

Details of the person discharging managerial responsibilities

a)

Name

Philip Wale

2

Reason for the notification

a)

Position/status

CEO

b)

Initial notification/amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

WH Ireland Group plc

b)

LEI

213800HB9TO5O4WD6S66

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.5 pence each

 

GB0009241885

b)

Nature of the transaction

Market purchases

c)

Price(s) and volume(s)

Price(s)

Volume(s)

46p per share

35,000

 

 

 

d)

Aggregated information

-  Aggregated volume

 -  Price

 

35,000

46p

e)

Date of the transaction

20 January 2022

f)

Place of the transaction

London Stock Exchange (XLON)

 

 

For further information please contact:

WH Ireland Group plc 

www.whirelandplc.com

Phillip Wale, Chief Executive Officer

+44(0) 20 7220 1666

 

 

Canaccord Genuity Limited

www.canaccordgenuity.com

Emma Gabriel / Tom Diehl 

+44(0) 20 3368 3555

 

 

MHP Communications

[email protected]

Reg Hoare / James Bavister 

+44 (0) 20 3128 8793

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHGZGZMNDZGZZM